Emerging market healthcare investing blog

The emerging-market EM corporate bond market in particular presents a tantalizing prospect for investors: Its size and strong historical performance make it impossible to ignore. But emerging markets also pose significant and complex challenges. Some challenges—such as inconsistent regulations and a lack of standardization across countries—reflect the diverse nature of emerging markets.

But others, such as the seemingly intractable problems of pollution and corruption—are ESG risks. These risks can be material. Our analysis shows that, from through , two-thirds of the worst-performing credits in the J. NMC Healthcare illustrates how governance risk can adversely affect investors.

Similarly, Chilean coal-fired power company Guacolda Energia saw its bond price—and bond ratings—plunge when it resisted diversifying away from coal toward renewable resources, which led to difficulty securing long-term contracts. Ranked by order of preference, private investors are targeting industrial, financial, healthcare and consumer good and retail.

On the other hand, public investors prefer infrastructure, consumer goods and retail, technology and financial sector. Overall, financial sector, consumer goods and retails are top on the agenda for all category of investors. While all the sectors related to the SDGs, the different preferences of the private institutional investors suggest a challenge, but also an opportunity to attract more private institutional investors into sectors that are more SDG intense such as infrastructure.

Investors face well-known constraints when considering the expansion of or new alternative investments in EMDEs through debt and equity financing: The top five macro constraints include: political risk, credit and forex risk, liquidity and exit, macroeconomic environment currency volatility, inflation, public debt, trade barriers , rule of law and contract enforcement as well as deal quality.

All three Bank Group institutions offer guarantees to support investor participation, in the form of partial risk, partial credit, political risk etc. Investors believe that multilateral development banks have an important role to play in fostering the environment for institutional investor capital flows. The World Bank Group has been scaling up first-loss facilities, project development fund, and introduced capital market solutions that can address, in part, institutional investor expectations.

The above IEG survey findings suggest there remain many challenges and but also enhanced opportunities and hope for attracting investors to EMDEs.

Healthcare emerging blog market investing gann forex calculator software

Right! good espanyol vs levante betting expert tennis agree

Find out more EM health spending to outpace GDP growth EM policymakers are aggressively seeking to catch up to their DM counterparts in terms of healthcare quality and accessibility. China in particular is spearheading the EM healthcare revolution. It has embarked on the most ambitious healthcare reform programs in history by targeting a seven-fold increase in medical spending from to This upsurge in public spending, for example, aims to increase the number of hospital beds for every 1, people from 4.

This is likely to prove a boon for private hospital groups, pharmaceutical firms and ambulance services. Traveling farther for healthcare Medical tourism is another potential source of EM growth and opportunity. Some emerging countries have carved out specialist or low-cost niches.

South Korea, for example, has become a regional hub for cosmetic surgery. The company is building digital stethoscopes, otoscopes, thermometers, high-definition camera tools, and more telehealth tools to support a digital primary care service for consumers across the continent. More Demand for Digital Health Governance and Regulation Digital health is largely driven by innovators operating outside of government. As the digital health field takes off, we expect to see more questions around the role of government in integrating digital health within existing local healthcare systems, setting standards, managing and shepherding data, and encouraging interoperability across numerous, proliferating digital health platforms.

To that end, the World Health Organization WHO has developed a Global Strategy on Digital Health that prioritizes the need for stronger global and national governance of digital health. With the right oversight and regulatory guidance, digital health can be a powerful tool for building a healthier, safer and fairer world.

Vaccine access continues to be a pressing issue for emerging markets worldwide. Many may not gain broad vaccine coverage until , resulting in sustained COVID cases, the rise of new variants like Delta and Omicron, additional mortalities, and pushing tens of millions of people into poverty. The organizations and several others assert that the quality and quantity of vaccine donations to LMICs must improve to avoid stressing already stretched domestic health systems.

In the coming year, we expect to see greater advocacy, innovation, and coordination to address debilitating health inequities related to how we anticipate, manage, and combat the pandemic on a global scale.

New Treatment Models for Noncommunicable Diseases Pre-pandemic, global organizations were beginning to emphasize chronic, noncommunicable diseases NCDs like heart disease, diabetes, and cancer, which collectively represent the leading cause of death globally. NCDs have historically been difficult—and expensive—to treat, particularly in emerging markets, where health infrastructure is often underdeveloped. But the relative affordability of telehealth puts the cost of care within reach for millions of new patients.

Digital tools and apps also better suit the nature of the regular, ongoing care needed to improve and sustain outcomes for NCDs. But true success will require a concerted, broad-based effort. Expanded health access and sustainable growth of promising new digital health solutions will require inclusive innovation, collaboration across the global health ecosystem , and novel digital health business models tailored to emerging markets.